{"id":"https://openalex.org/W2789510102","doi":"https://doi.org/10.1161/circulationaha.117.031676","title":"Response by Kusters et al to Letter Regarding Article, \u201cEffect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)\u201d","display_name":"Response by Kusters et al to Letter Regarding Article, \u201cEffect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)\u201d","publication_year":2018,"publication_date":"2018-02-06","ids":{"openalex":"https://openalex.org/W2789510102","doi":"https://doi.org/10.1161/circulationaha.117.031676","mag":"2789510102","pmid":"https://pubmed.ncbi.nlm.nih.gov/29431667"},"language":"en","primary_location":{"id":"doi:10.1161/circulationaha.117.031676","doi":"https://doi.org/10.1161/circulationaha.117.031676","is_oa":true,"landing_page_url":"https://doi.org/10.1161/circulationaha.117.031676","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.117.031676","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"letter","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.117.031676","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051194824","display_name":"D. Meeike Kusters","orcid":"https://orcid.org/0000-0002-1894-841X","observed_orcids":["https://orcid.org/0000-0002-1894-841X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Meeike Kusters","raw_affiliation_strings":["Departments of Vascular Medicine (D.M.K., M.J.A.M.B., J.J.P.K.)","Pediatrics (D.M.K., M.J.A.M.B., A.W.)","D. Meeike Kusters Departments of Vascular Medicine (D.M.K., M.J.A.M.B., J.J.P.K.) Pediatrics (D.M.K., M.J.A.M.B., A.W.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Vascular Medicine (D.M.K., M.J.A.M.B., J.J.P.K.)","institution_ids":[]},{"raw_affiliation_string":"Pediatrics (D.M.K., M.J.A.M.B., A.W.)","institution_ids":[]},{"raw_affiliation_string":"D. Meeike Kusters Departments of Vascular Medicine (D.M.K., M.J.A.M.B., J.J.P.K.) Pediatrics (D.M.K., M.J.A.M.B., A.W.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071470109","display_name":"Marjet J.A.M. Braamskamp","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marjet J.A.M. Braamskamp","raw_affiliation_strings":["Departments of Vascular Medicine (D.M.K., M.J.A.M.B., J.J.P.K.)","Pediatrics (D.M.K., M.J.A.M.B., A.W.)","Marjet J.A.M. Braamskamp Departments of Vascular Medicine (D.M.K., M.J.A.M.B., J.J.P.K.) Pediatrics (D.M.K., M.J.A.M.B., A.W.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Vascular Medicine (D.M.K., M.J.A.M.B., J.J.P.K.)","institution_ids":[]},{"raw_affiliation_string":"Pediatrics (D.M.K., M.J.A.M.B., A.W.)","institution_ids":[]},{"raw_affiliation_string":"Marjet J.A.M. Braamskamp Departments of Vascular Medicine (D.M.K., M.J.A.M.B., J.J.P.K.) Pediatrics (D.M.K., M.J.A.M.B., A.W.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009467334","display_name":"Gisle Langslet","orcid":"https://orcid.org/0000-0003-4034-2243","observed_orcids":["https://orcid.org/0000-0003-4034-2243"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Gisle Langslet","raw_affiliation_strings":["Lipid Clinic, Medical Department, Oslo University Hospital, Norway (G.C.)","Gisle Langslet Lipid Clinic, Medical Department, Oslo University Hospital, Norway (G.C.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lipid Clinic, Medical Department, Oslo University Hospital, Norway (G.C.)","institution_ids":["https://openalex.org/I1281400175"]},{"raw_affiliation_string":"Gisle Langslet Lipid Clinic, Medical Department, Oslo University Hospital, Norway (G.C.)","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027489789","display_name":"Brian W. McCrindle","orcid":"https://orcid.org/0000-0001-6485-6551","observed_orcids":["https://orcid.org/0000-0001-6485-6551"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2801317318","display_name":"Hospital for Sick Children","ror":"https://ror.org/057q4rt57","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801317318"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Brian W. McCrindle","raw_affiliation_strings":["Department of Pediatrics, University of Toronto, Labatt Family Health Center, The Hospital for Sick Children, Canada (B.W.C.)","Brian W. McCrindle Department of Pediatrics, University of Toronto, Labatt Family Health Center, The Hospital for Sick Children, Canada (B.W.C.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, University of Toronto, Labatt Family Health Center, The Hospital for Sick Children, Canada (B.W.C.)","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2801317318"]},{"raw_affiliation_string":"Brian W. McCrindle Department of Pediatrics, University of Toronto, Labatt Family Health Center, The Hospital for Sick Children, Canada (B.W.C.)","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2801317318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028321574","display_name":"David M Cassiman","orcid":"https://orcid.org/0000-0002-6154-0970","observed_orcids":["https://orcid.org/0000-0002-6154-0970"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"David Cassiman","raw_affiliation_strings":["Department of Hepatology and Metabolic Center, University Hospitals Leuven, Belgium (D.C.)","David Cassiman Department of Hepatology and Metabolic Center, University Hospitals Leuven, Belgium (D.C.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatology and Metabolic Center, University Hospitals Leuven, Belgium (D.C.)","institution_ids":["https://openalex.org/I2800231306"]},{"raw_affiliation_string":"David Cassiman Department of Hepatology and Metabolic Center, University Hospitals Leuven, Belgium (D.C.)","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045044313","display_name":"Gordon A. Francis","orcid":"https://orcid.org/0000-0002-1691-3758","observed_orcids":["https://orcid.org/0000-0002-1691-3758"]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]},{"id":"https://openalex.org/I2801362399","display_name":"St. Paul's Hospital","ror":"https://ror.org/00wzdr059","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801362399"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Gordon A. Francis","raw_affiliation_strings":["Department of Medicine, University of British Columbia, Vancouver, Canada (G.A.F.)","Healthy Heart Program Prevention Clinic, St. Paul\u2019s Hospital, Vancouver, Canada (G.A.F.)","Gordon A. Francis Healthy Heart Program Prevention Clinic, St. Paul's Hospital, Vancouver, Canada (G.A.F.) Department of Medicine, University of British Columbia, Vancouver, Canada (G.A.F.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of British Columbia, Vancouver, Canada (G.A.F.)","institution_ids":["https://openalex.org/I141945490"]},{"raw_affiliation_string":"Healthy Heart Program Prevention Clinic, St. Paul\u2019s Hospital, Vancouver, Canada (G.A.F.)","institution_ids":["https://openalex.org/I2801362399"]},{"raw_affiliation_string":"Gordon A. Francis Healthy Heart Program Prevention Clinic, St. Paul's Hospital, Vancouver, Canada (G.A.F.) Department of Medicine, University of British Columbia, Vancouver, Canada (G.A.F.)","institution_ids":["https://openalex.org/I141945490","https://openalex.org/I2801362399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113564094","display_name":"Claude Gagn\u00e9","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claude Gagne","raw_affiliation_strings":["Clinique des Maladies Lipidiques de Qu\u00e9bec Inc, Canada (C.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinique des Maladies Lipidiques de Qu\u00e9bec Inc, Canada (C.G.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090781778","display_name":"Daniel Gaudet","orcid":"https://orcid.org/0000-0002-5185-3666","observed_orcids":["https://orcid.org/0000-0002-5185-3666"]},"institutions":[{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Daniel Gaudet","raw_affiliation_strings":["Department of Medicine, Universit\u00e9 de Montr\u00e9al, Canada (D.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Canada (D.G.)","institution_ids":["https://openalex.org/I70931966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040727760","display_name":"Katherine Mary Morrison","orcid":"https://orcid.org/0000-0002-1737-256X","observed_orcids":["https://orcid.org/0000-0002-1737-256X"]},"institutions":[{"id":"https://openalex.org/I98251732","display_name":"McMaster University","ror":"https://ror.org/02fa3aq29","country_code":"CA","type":"education","lineage":["https://openalex.org/I98251732"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Katherine M. Morrison","raw_affiliation_strings":["Department of Pediatrics, McMaster University, Hamilton, Canada (K.M.M.)","Katherine M. Morrison Department of Pediatrics, McMaster University, Hamilton, Canada (K.M.M.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, McMaster University, Hamilton, Canada (K.M.M.)","institution_ids":["https://openalex.org/I98251732"]},{"raw_affiliation_string":"Katherine M. Morrison Department of Pediatrics, McMaster University, Hamilton, Canada (K.M.M.)","institution_ids":["https://openalex.org/I98251732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020436935","display_name":"Albert Wiegman","orcid":"https://orcid.org/0000-0001-6223-5671","observed_orcids":["https://orcid.org/0000-0001-6223-5671"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Albert Wiegman","raw_affiliation_strings":["Pediatrics (D.M.K., M.J.A.M.B., A.W.)","Albert Wiegman Pediatrics (D.M.K., M.J.A.M.B., A.W.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatrics (D.M.K., M.J.A.M.B., A.W.)","institution_ids":[]},{"raw_affiliation_string":"Albert Wiegman Pediatrics (D.M.K., M.J.A.M.B., A.W.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012438216","display_name":"Traci A. Turner","orcid":"https://orcid.org/0000-0001-9841-2967","observed_orcids":["https://orcid.org/0000-0001-9841-2967"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Traci Turner","raw_affiliation_strings":["Metabolic & Atherosclerosis Research Center, Cincinnati, OH (T.T., E.A.S.)","Traci Turner Metabolic & Atherosclerosis Research Center, Cincinnati, OH (T.T., E.A.S.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Metabolic & Atherosclerosis Research Center, Cincinnati, OH (T.T., E.A.S.)","institution_ids":[]},{"raw_affiliation_string":"Traci Turner Metabolic & Atherosclerosis Research Center, Cincinnati, OH (T.T., E.A.S.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108410368","display_name":"Elinor Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elinor Miller","raw_affiliation_strings":["AstraZeneca Pharmaceuticals LP, Wilmington, DE (E.M., J.R.)","Elinor Miller AstraZeneca Pharmaceuticals LP, Wilmington, DE (E.M., J.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca Pharmaceuticals LP, Wilmington, DE (E.M., J.R.)","institution_ids":["https://openalex.org/I4210150756"]},{"raw_affiliation_string":"Elinor Miller AstraZeneca Pharmaceuticals LP, Wilmington, DE (E.M., J.R.)","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111866043","display_name":"Joel S. Raichlen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel Raichlen","raw_affiliation_strings":["AstraZeneca Pharmaceuticals LP, Wilmington, DE (E.M., J.R.)","Joel Raichlen AstraZeneca Pharmaceuticals LP, Wilmington, DE (E.M., J.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca Pharmaceuticals LP, Wilmington, DE (E.M., J.R.)","institution_ids":["https://openalex.org/I4210150756"]},{"raw_affiliation_string":"Joel Raichlen AstraZeneca Pharmaceuticals LP, Wilmington, DE (E.M., J.R.)","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102851619","display_name":"Paul D. Martin","orcid":"https://orcid.org/0009-0002-2598-4520","observed_orcids":["https://orcid.org/0009-0002-2598-4520"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul D. Martin","raw_affiliation_strings":["AstraZeneca, Macclesfield, UK (P.D.M.)","Paul D. Martin AstraZeneca, Macclesfield, UK (P.D.M.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Macclesfield, UK (P.D.M.)","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Paul D. Martin AstraZeneca, Macclesfield, UK (P.D.M.)","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049272753","display_name":"Evan A. Stein","orcid":"https://orcid.org/0000-0001-7147-5394","observed_orcids":["https://orcid.org/0000-0001-7147-5394"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evan A. Stein","raw_affiliation_strings":["Metabolic & Atherosclerosis Research Center, Cincinnati, OH (T.T., E.A.S.)","Evan A. Stein Metabolic & Atherosclerosis Research Center, Cincinnati, OH (T.T., E.A.S.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Metabolic & Atherosclerosis Research Center, Cincinnati, OH (T.T., E.A.S.)","institution_ids":[]},{"raw_affiliation_string":"Evan A. Stein Metabolic & Atherosclerosis Research Center, Cincinnati, OH (T.T., E.A.S.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077848934","display_name":"John J.P. Kastelein","orcid":"https://orcid.org/0000-0003-2018-4532","observed_orcids":["https://orcid.org/0000-0003-2018-4532"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John J.P. Kastelein","raw_affiliation_strings":["Departments of Vascular Medicine (D.M.K., M.J.A.M.B., J.J.P.K.)","John J.P. Kastelein Departments of Vascular Medicine (D.M.K., M.J.A.M.B., J.J.P.K.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Vascular Medicine (D.M.K., M.J.A.M.B., J.J.P.K.)","institution_ids":[]},{"raw_affiliation_string":"John J.P. Kastelein Departments of Vascular Medicine (D.M.K., M.J.A.M.B., J.J.P.K.)","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015459043","display_name":"Barbara A. Hutten","orcid":"https://orcid.org/0000-0002-9243-0037","observed_orcids":["https://orcid.org/0000-0002-9243-0037"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Barbara A. Hutten","raw_affiliation_strings":["Clinical Epidemiology, Biostatistics and Bioinformatics (B.A.H.), Academic Medical Center, Amsterdam, the Netherlands","Barbara A. Hutten Clinical Epidemiology, Biostatistics and Bioinformatics (B.A.H.), Academic Medical Center, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Epidemiology, Biostatistics and Bioinformatics (B.A.H.), Academic Medical Center, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900"]},{"raw_affiliation_string":"Barbara A. Hutten Clinical Epidemiology, Biostatistics and Bioinformatics (B.A.H.), Academic Medical Center, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"137","issue":"6","first_page":"641","last_page":"642"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10924","display_name":"Cardiovascular Health and Disease Prevention","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/heterozygous-familial-hypercholesterolemia","display_name":"heterozygous familial hypercholesterolemia","score":0.9480000138282776},{"id":"https://openalex.org/keywords/carotid-intima-media-thickness","display_name":"carotid intima-media thickness","score":0.9890000224113464},{"id":"https://openalex.org/keywords/children","display_name":"children","score":0.5920000076293945},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.7409999966621399},{"id":"https://openalex.org/keywords/cardiovascular-risk-in-children","display_name":"cardiovascular risk in children","score":0.4059999883174896}],"concepts":[{"id":"https://openalex.org/C2780499067","wikidata":"https://www.wikidata.org/wiki/Q415159","display_name":"Rosuvastatin","level":2,"score":0.7896116375923157},{"id":"https://openalex.org/C2779120738","wikidata":"https://www.wikidata.org/wiki/Q2711291","display_name":"Familial hypercholesterolemia","level":3,"score":0.7873384356498718},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.735562801361084},{"id":"https://openalex.org/C2779339615","wikidata":"https://www.wikidata.org/wiki/Q2698596","display_name":"Intima-media thickness","level":3,"score":0.6353269219398499},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.40490493178367615},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3641064763069153},{"id":"https://openalex.org/C2987047532","wikidata":"https://www.wikidata.org/wiki/Q214275","display_name":"Carotid arteries","level":2,"score":0.3217132091522217},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.22274142503738403}],"mesh":[{"descriptor_ui":"D000068718","descriptor_name":"Rosuvastatin Calcium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018542","descriptor_name":"Pluto","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D059168","descriptor_name":"Carotid Intima-Media Thickness","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1161/circulationaha.117.031676","doi":"https://doi.org/10.1161/circulationaha.117.031676","is_oa":true,"landing_page_url":"https://doi.org/10.1161/circulationaha.117.031676","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.117.031676","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},{"id":"pmid:29431667","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29431667","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Letter"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/c3603f9c-8c73-4853-90a2-ca4c723db5b6","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/response-by-kusters-et-al-to-letter-regarding-article-effect-of-rosuvastatin-on-carotid-intimamedia-thickness-in-children-with-heterozygous-familial-hypercholesterolemia-the-charon-study-hypercholesterolemia-in-children-and-adolescents-taking-rosuvastatin-open-label(c3603f9c-8c73-4853-90a2-ca4c723db5b6).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Circulation, 137(6), 641 - 642. Lippincott Williams and Wilkins","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/615908","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29431667","pdf_url":null,"source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Circulation, vol. 137 (6), (641-642)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire/547ce222-3afe-4a44-a52e-07b7ff90a664","doi":null,"is_oa":true,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/547ce222-3afe-4a44-a52e-07b7ff90a664","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/annotation"}],"best_oa_location":{"id":"doi:10.1161/circulationaha.117.031676","doi":"https://doi.org/10.1161/circulationaha.117.031676","is_oa":true,"landing_page_url":"https://doi.org/10.1161/circulationaha.117.031676","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.117.031676","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320311526","display_name":"McMaster University","ror":"https://ror.org/02fa3aq29"},{"id":"https://openalex.org/F4320322015","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087"},{"id":"https://openalex.org/F4320323175","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34"},{"id":"https://openalex.org/F4320323654","display_name":"Hospital for Sick Children","ror":"https://ror.org/057q4rt57"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2789510102.pdf","grobid_xml":"https://content.openalex.org/works/W2789510102.grobid-xml"},"referenced_works_count":4,"referenced_works":["https://openalex.org/W1113293211","https://openalex.org/W1970484759","https://openalex.org/W2033796658","https://openalex.org/W2738197143"],"related_works":["https://openalex.org/W2791266844","https://openalex.org/W2046727692","https://openalex.org/W2006450931","https://openalex.org/W2039357029","https://openalex.org/W2899635659","https://openalex.org/W2738197143","https://openalex.org/W2289505772","https://openalex.org/W2105348343","https://openalex.org/W1982497368","https://openalex.org/W3199762552"],"abstract_inverted_index":{"sponsorship:":[0],"Dr":[1,16,36,49,69,86,104,112,125,170],"Langslet":[2],"has":[3,18,51,71,88,106,114,127,172],"received":[4,19,107,115,128,173],"advisory":[5],"board":[6,58],"fees":[7,21,120,143,157],"from":[8,22,34,110,121,131,144,158,181],"Amgen,":[9,65,77,98],"Sanofi,":[10,66,199],"Boehringer":[11,153,200],"Ingelheim,":[12,201],"and":[13,27,31,67,84,102,117,140,152,155,168,179,186],"Janssen":[14,202],"Pharmaceuticals.":[15],"McCrindle":[17],"consulting":[20,156],"Eli":[23,204],"Lilly,":[24,205],"Medpace,":[25,206],"Merck,":[26,136,166,207],"Bristol":[28,208],"Myers":[29,209],"Squibb":[30],"research":[32,108],"support":[33,109,130],"AstraZeneca.":[35,111,191],"Cassiman":[37],"serves":[38],"as":[39,90],"a":[40,53,91],"clinical":[41],"investigator":[42],"for":[43,46,95,177],"the":[44,56],"Fund":[45],"Scientific":[47],"Research-Flanders.":[48],"Francis":[50],"been":[52],"member":[54],"of":[55,190],"speakers":[57],"or":[59,93],"an":[60,174],"advisor":[61,94],"to":[62],"Aegerion,":[63],"Alexion,":[64],"Valeant.":[68],"Gagne":[70],"participated":[72],"in":[73],"studies":[74],"sponsored":[75],"by":[76],"AstraZeneca,":[78,96,132,145,159,211],"Genzyme,":[79,139,163,212],"Isis,":[80,100,138,151,162,213],"Merck/Schering-Plow,":[81,137,149,167,214],"Pfizer,":[82,133,147,161,215],"Regeneron,":[83,97,216],"Sanofi.":[85],"Gaudet":[87],"served":[89],"consultant":[92,116],"Novartis,":[99,135,148,165,218],"Uniqure,":[101],"Catabasis.":[103],"Morrison":[105],"Stein":[113],"expert":[118],"witness":[119],"AstraZeneca":[122],"regarding":[123],"statins.":[124],"Kastelein":[126],"grant":[129,176],"Roche,":[134,150,164,217],"Sanofi-Aventis;":[141],"lecture":[142],"GlaxoSmithKline,":[146,220],"Ingelheim;":[154],"Abbott,":[160],"Sanofi-Aventis.":[169],"Hutten":[171],"independent":[175],"learning":[178],"change":[180],"Pfizer.":[182],"Drs":[183],"Miller,":[184],"Raichlen,":[185],"Martin":[187],"are":[188],"employees":[189],"The":[192],"other":[193],"authors":[194],"report":[195],"no":[196],"conflicts.":[197],"(Amgen,":[198],"Pharmaceuticals,":[203],"Squibb,":[210],"Sanofi-Aventis,":[219],"Abbott)":[221]},"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-03-29T00:00:00"}